IL6 and psoriasis: In the pathogenesis of psoriasis, PRINS inhibits the expression of cellular inflammatory factors [e.g., interleukin (IL)-1α, IL-1β, IL-6, IL-8, and tumor necrosis factor-α) and thus affects inflammatory responses (38).